Algert Global’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-37,390
| Closed | -$40K | – | 1300 |
|
|
2023
Q3 | $40K | Sell |
37,390
-99,860
| -73% | -$107K | ﹤0.01% | 1075 |
|
|
2023
Q2 | $355K | Sell |
137,250
-15,010
| -10% | -$38.8K | 0.02% | 881 |
|
|
2023
Q1 | $621K | Buy |
152,260
+78,370
| +106% | +$320K | 0.03% | 773 |
|
|
2022
Q4 | $371K | Sell |
73,890
-3,950
| -5% | -$19.8K | 0.02% | 886 |
|
|
2022
Q3 | $1.02M | Buy |
77,840
+5,877
| +8% | +$76.9K | 0.06% | 534 |
|
|
2022
Q2 | $923K | Buy |
71,963
+43,050
| +149% | +$552K | 0.07% | 517 |
|
|
2022
Q1 | $441K | Buy |
28,913
+8,267
| +40% | +$126K | 0.03% | 854 |
|
|
2021
Q4 | $366K | Buy |
+20,646
| New | +$366K | 0.05% | 660 |
|